Two partial β2AR agonists with new
activating chemotypes
in their docked poses. (A) The docked pose of isoproterenol, with
a salt-bridge between the amine group and key residue Asp1133.32 and hydrogen bonds to Ser2035.42, Ser2045.43, and Ser2075.46 in TM5. The co-crystal ligand BI-167107
is shown in black sticks. Previously unreported (B) imidazole, compound 10, and (C) amino-purine, compound 14, polar
head groups make activating hydrogen bonds with TM5.